Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 2/2014

01-11-2014 | Editorial

Passive smoke exposure and type-2 diabetes: is it time for action?

Authors: Fabrizio Faggiano, Elias Allara

Published in: Endocrine | Issue 2/2014

Login to get access

Excerpt

In a recent meta-analysis [1] of six cohort studies, Sun et al. found evidence of a 21 % increased risk of type-2 diabetes or glucose intolerance among subjects exposed to passive smoking (95 % CI 7–38 %) compared to those who were not exposed. The authors conclude that such association may have a ‘far-reaching significance’ for public health. At a first glance, such conclusion might be justified. The meta-analysis appears to have good methodological quality, including an adequately powered pooled sample size (n = 154,406) and using a random effects model to address between study heterogeneity. …
Literature
1.
K. Sun, D. Liu, C. Wang, M. Ren, C. Yang, L. Yan, Passive smoke exposure and risk of diabetes: a meta-analysis of prospective studies. Endocrine. (2014). doi:10.​1007/​s12020-014-0194-1
2.
A. Bradford-Hill, The environment and disease: association or causation? Proc. R. Soc. Med. 58, 295–300 (1965)
3.
U.S. Department of Health and Human Services, The Health Consequences of Smoking—50 Years of Progress. A Report of the Surgeon General (U.S. Department of Health and Human Services, Atlanta, 2014)
4.
B. Charbotel, B. Fervers, J.P. Droz, Occupational exposures in rare cancers: a critical review of the literature. Crit. Rev. Oncol. Hematol. 90, 99–134 (2014)PubMedCrossRef
5.
Y. Wang, J. Ji, Y. Liu, X. Deng, Q. He, Passive smoking and risk of type 2 diabetes: a meta-analysis of prospective cohort studies. PLoS ONE 8, e69915 (2013)PubMedCrossRefPubMedCentral
6.
B. Zhu, X. Wu, X. Wang, Q. Zheng, G. Sun, The Association between passive smoking and type 2 diabetes: a meta-analysis. Asia Pac. J. Public Health 26, 226–237 (2014)PubMedCrossRef
7.
International Agency for Research on Cancer (IARC), Tobacco smoking, in IARC. A Review of Human Carcinogens. Part E: Personal Habits and Indoor Combustions IARC Monographs, vol 100E (Lyon, France, 2012)
8.
International Agency for Research on Cancer (IARC), Second-hand tobacco smoke, in IARC. A Review of Human Carcinogens. Part E: Personal Habits and Indoor Combustions IARC Monographs, vol 100E (Lyon, France, 2012)
9.
L. Zhang, G.C. Curhan, F.B. Hu, E.B. Rimm, J.P. Forman, Association between passive and active smoking and incident type 2 diabetes in women. Diabetes Care 34, 892–897 (2011)PubMedCrossRefPubMedCentral
10.
T.K. Houston, S.D. Person, M.J. Pletcher, K. Liu, C. Iribarren, C.I. Kiefe, Active and passive smoking and development of glucose intolerance among young adults in a prospective cohort: CARDIA study. BMJ 332, 1064–1069 (2006)PubMedCrossRefPubMedCentral
11.
B. Kowall, W. Rathmann, K. Strassburger, M. Heier, R. Holle, B. Thorand, G. Giani, A. Peters, C. Meisinger, Association of passive and active smoking with incident type 2 diabetes mellitus in the elderly population: the KORA S4/F4 cohort study. Eur. J. Epidemiol. 25, 393–402 (2010)PubMedCrossRef
12.
M. Lajous, L. Tondeur, G. Fagherazzi, B. de Lauzon-Guillain, M.-C. Boutron-Ruaualt, F. Clavel-Chapelon, Childhood and adult secondhand smoke and type 2 diabetes in women. Diabetes Care 36, 2720–2725 (2013)PubMedCrossRefPubMedCentral
13.
K.-P. Ko, H. Min, Y. Ahn, S.-J. Park, C.-S. Kim, J.K. Park, S.S. Kim, A prospective study investigating the association between environmental tobacco smoke exposure and the incidence of type 2 diabetes in never smokers. Ann. Epidemiol. 21, 42–47 (2011)PubMedCrossRef
14.
Y. Hayashino, S. Fukuhara, T. Okamura, H. Yamato, H. Tanaka, T. Tanaka, T. Kadowaki, H. Ueshima, A prospective study of passive smoking and risk of diabetes in a cohort of workers: the High-Risk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) study. Diabetes Care 31, 732–734 (2008)PubMedCrossRef
15.
G. Danaei, M.M. Finucane, Y. Lu, G.M. Singh, M.J. Cowan, C.J. Paciorek, J.K. Lin, F. Farzadfar, Y.-H. Khang, G.A. Stevens, M. Rao, M.K. Ali, L.M. Riley, C.A. Robinson, M. Ezzati, National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet 378, 31–40 (2011)PubMedCrossRef
16.
17.
World Health Organization (WHO), Protection from exposure to second-hand tobacco smoke. Policy recommendations (World Health Organization (WHO), Geneva, 2007)
Metadata
Title
Passive smoke exposure and type-2 diabetes: is it time for action?
Authors
Fabrizio Faggiano
Elias Allara
Publication date
01-11-2014
Publisher
Springer US
Published in
Endocrine / Issue 2/2014
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0430-8

Other articles of this Issue 2/2014

Endocrine 2/2014 Go to the issue

Original Article

Glucocorticoids activate the local renin–angiotensin system in bone: possible mechanism for glucocorticoid-induced osteoporosis

Meta-Analysis

Associations between rs965513/rs944289 and papillary thyroid carcinoma risk: a meta-analysis

Editorial

Thyroid fine-needle aspiration: the relevance of BRAF mutation testing

Editorial

Emerging data on cardiovascular risk in primary hyperparathyroidism

Original Article

Contribution of protein kinase Cα in the stimulation of insulin by the down-regulation of Cavβ subunits

Original Article

Dexamethasone altered steroidogenesis and changed redox status of granulosa cells
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits